Display Settings:

Format

Send to:

Choose Destination
    J Med Chem. 2008 Oct 23;51(20):6599-603. Epub 2008 Sep 20.

    Solution kinetics measurements suggest HIV-1 protease has two binding sites for darunavir and amprenavir.

    Source

    Departments of Biology and Chemistry, Molecular Basis of Disease Program, Georgia State University, Atlanta, Georgia 30303, USA.

    Abstract

    Darunavir, a potent antiviral drug, showed an unusual second binding site on the HIV-1 protease dimer surface of the V32I drug resistant mutant and normal binding in the active site cavity. Kinetic analysis for wild type and mutant protease showed mixed-type competitive-uncompetitive inhibition for darunavir and the chemically related amprenavir, while saquinavir showed competitive inhibition. The inhibition model is consistent with the observed second binding site for darunavir and helps to explain its antiviral potency.

    PMID:
    18808097
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2771923
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 1
    Figure 2

      Supplemental Content

      Icon for American Chemical Society Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk